Aldara

Aldara (imiquimod) cream for early skin cancer and sun damage

Aldara (imiquimod) is a prescription immune-activating cream used to treat selected, thin skin cancers and sun-damage “precancer” (actinic keratoses). At The Skin Doctor, we use Aldara (imiquimod) mainly for:

If you’re deciding between topical treatments, also read:

Quick comparison

Comparison of Aldara to other field actinic keratosis treatments (Jump to table 1 below Field Treatment Comparison: Actinic Keratosis (AK))

Comparison of Aldara to other non melanoma skin cancer  treatments (jump to table 2 below) 

Book a 20 minute appointment with Dr Chris (Skin cancer treatment discussion)

When Aldara (imiquimod) is a good option

Aldara (imiquimod) can be a good choice when:

Aldara (imiquimod) is not suitable for every lesion. Depth, subtype, location, immune status, and diagnostic certainty matter.

If you have one to three spots you’re worried about, start with (Targeted Skin Spot Check (Up to 3 lesions)).

How Aldara (imiquimod) works

Aldara (imiquimod) activates immune signalling in the skin (including Toll-like receptor pathways), which helps your body recognise and destroy abnormal cells. (8,9)

A key concept: Aldara (imiquimod) works by creating an immune reaction. Some redness and inflammation is expected — and often correlates with response — but we still want the reaction to remain safe and controlled. (1–3)

How effective is Aldara (imiquimod)?

For properly selected superficial lesions, studies show clearance rates in the roughly 70–80% range depending on the protocol and how clearance is defined (clinical vs histological). (1–3)

For context, surgical removal of a suitable low-risk lesion usually has a higher cure rate, but involves a scar and surgical downsides. (10)

What patients often like about Aldara (imiquimod):

Aldara (imiquimod) vs Efudix (5-fluorouracil): which is “easier”?

People often find Aldara (imiquimod) more tolerable than Efudix (5-fluorouracil), but reactions vary widely.

If you’re treating actinic keratoses (AK), we often prefer Efudix (5-fluorouracil) because the course can be more convenient and predictable — but Aldara (imiquimod) can still be appropriate in selected situations. (6,7)

Compare: (Efudix (5-fluorouracil))

How much Aldara (imiquimod) should I use?

More is not better.

A practical guide:

If you accidentally use too much, don’t panic — just use a little less next time.

How to use Aldara (imiquimod): step-by-step

Your exact plan should come from your doctor. A common regimen for selected superficial skin cancers is:

1) Timing

Apply Aldara (imiquimod) 2–3 hours before bed so it can absorb and won’t rub off onto bedding. (6,7)

2) Clean the area

3) Apply correctly

4) Don’t occlude unless instructed

Do not cover the area with an airtight dressing unless your doctor tells you to. Occlusion can intensify the reaction and may increase side-effect risk. (6,7)

If you need cosmetic cover, a light, non-occlusive dressing may be reasonable — discuss this with your doctor first.

5) After applying

6) Treatment area limits

Do not treat large areas unless specifically instructed. Product information limits treatment area and provides guidance on maximum surface area. (6,7)

7) Review after treatment

We normally review the area after the course is finished (often including dermoscopy) to check response and decide if further treatment or biopsy is needed.

What should I expect during treatment?

A typical timeline:

Some areas (for example, the side of the nose) can swell and look dramatic. This can be normal — but if you’re worried, contact your treating doctor.

Side effects and risks of Aldara (imiquimod)

Aldara (imiquimod) is usually well tolerated when used correctly, but side effects can occur. (6,7)

Common local effects

Pigment change (darkening or lightening)

Any significant inflammation can disrupt pigment cells and cause lighter or darker patches. Risk is higher if you get UV exposure during/after treatment.

Strict sun avoidance and sunscreen are important during treatment and for weeks afterwards.

If you’re prone to pigmentation (e.g., melasma), discuss this before starting:

Scarring (uncommon, but possible)

Most people do not scar, but intense inflammation can scar in susceptible individuals. If scarring risk is a major concern, discuss alternatives such as:

Worsening facial redness / rosacea-type vessels (rare)

Inflammation can sometimes unmask or worsen facial redness and visible vessels. If you already have rosacea or you’re redness-prone, discuss options first:

Non-healing ulcer (higher risk on lower legs)

Lower legs have relatively reduced blood supply, and inflammation can occasionally lead to delayed healing. Lower-leg lesions should be managed cautiously and under close review.

Infection (uncommon)

Treated skin can look alarming without being infected. Seek review promptly if you have rapidly spreading redness, increasing pain/warmth, pus, or fevers/feeling unwell.

Who should not use Aldara (imiquimod)?

Aldara (imiquimod) generally should be avoided or used only under specialist guidance in situations such as:

Always tell your doctor if you are pregnant, trying to conceive, or breastfeeding, or if you take immunosuppressive medication.

When to contact your doctor urgently

Stop and seek medical advice if you develop:

Alternatives patients commonly consider

Depending on diagnosis and site, alternatives may include:

Book an appointment

If you’ve been prescribed Aldara (imiquimod), or you’re deciding between creams, LA-PDT, and surgery, we can help you choose the safest, most effective pathway for your lesion type and location.

Book a 20 minute appointment with Dr Chris (Skin cancer treatment discussion)
 Or, for a few specific lesions: (Targeted Skin Spot Check (Up to 3 lesions))

Field Treatment Comparison: Actinic Keratosis (AK)

Feature LA-PDT (Laser-Assisted) Efudix (5-fluorouracil) Aldara (imiquimod)
Indicated For Multiple/Field AKs Multiple/Field AKs Multiple/Field AKs
Effectiveness ~90-95% clearance; highly effective for thick lesions. ~75% full clearance of visible lesions. ~70% – 85% clearance.
Delivery In-clinic, doctor-led At-home, self-applied At-home, self-applied
Mechanism

ablation + light-activated cell death.

 Topical chemotherapy; blocks DNA synthesis. Immune system stimulant; triggers local attack.
Visible Reaction Intense redness, crusting, and swelling (brief). Significant redness, erosion, and “angry” scabbing. Redness, weeping, and localized inflammation.
Systemic (Whole Body) Side Effects None 5–10% can develop flu-like illness, cramps, vomiting, or alopecia. Rare bone marrow suppression (life-threatening if DPD deficient). 5–10% can develop flu-like illness, headaches, dizziness, or fatigue.
Discontinuation (Severe Side Effects) None ~5% stop early due to severe reactions or pain. ~3% stop early due to systemic or local reactions.
Downtime Short: 7–10 days for most healing. Prolonged: 4–8 weeks (treatment + healing). Prolonged: 4–8 weeks (treatment + healing).
Cosmetic Outcome Excellent: Often improves overall skin texture. Good: Slightly higher risk of pigment changes or scarring. Also worsens rosacea. Good: Slightly higher risk of pigment changes or scarring. Also worsens rosacea.

Table 1.

Treatment Comparison comparing Aldara to other options for non melanoma skin cancer (NMSC): At-a-Glance

Feature LA-PDT (Laser-Assisted) Surgery Efudix (5-fluorouracil) Aldara (imiquimod)
Indicated For sBCC, SCCis, nBCC* (10-15) sBCC, SCCis, nBCC* SCCis (3) sBCC (2)
Effectiveness ~94% – 100% ((10-14)) ~97%  70% (8) ~80% (non-facial); 42–76% (facial) (9)
Delivery In-clinic, doctor-led In-clinic At-home, self-applied (3) At-home, self-applied (2)
Typical Course 1–2 sessions 1 session Twice daily for 6 weeks  5 days a week for 6 weeks
Mechanism Laser ablation + light-activated cell death Surgical excision Topical chemotherapy (3) Immune system stimulant (2)
Visible Reaction Red, weeping area Scarring  Red, weeping area  Red, weeping area
Systemic (whole body) side effects None None 5-10% can develop flu like illness, abdominal cramps, persistent vomiting, bloody diarrhoea, alopecia, rare bone marrow suppression. Very rarely life threatening (18,19). 5-10% can develop Flu like illness, headaches, dizziness, insomnia, diarrhoea(16,17,19).
Discontinuation before treatment complete due to severe side effects None None 5% (19) 3% (19)
Downtime Short (days) Weeks – 3 months (dependent on area and size) Prolonged (weeks- two months) Prolonged (weeks-two months
Cosmetic Outcome Excellent (10-14) Good (dependent on area and size) Good (risk of pigment changes) Good (risk of pigment changes)

Table 2. *nBCC indication for LA-PDT may be considered off-label depending on clinical selection (36).

Frequently asked questions (FAQ)

How long does Aldara (imiquimod) take to work?

Most people notice increasing redness and irritation over the first 2–4 weeks, with the peak reaction often occurring during weeks 3–6 depending on the regimen. Healing and “settling” can continue for several weeks after you stop. (6,7)

Is a strong reaction a good sign?

A visible inflammatory response is common and often expected, because Aldara (imiquimod) works by activating local immune responses. But “stronger” isn’t always “better” — excessive ulceration or severe pain can increase complication risk and may need a pause or review. (6,7)

What if the area gets too painful or angry?

Contact your treating doctor. Common adjustments include short treatment breaks, changing frequency, and supporting the skin barrier with bland moisturisers. Do not “push through” severe pain, large ulcers, or rapidly worsening swelling without review. (6,7)

Can I put moisturiser on while using Aldara (imiquimod)?

Often yes, but timing matters. Many people apply moisturiser after the medication has been on the skin for a period (for example, after ~20 minutes) and choose bland, fragrance-free products. If moisturiser stings or worsens the reaction, stop and discuss alternatives with your doctor. (6,7)

Can I wear sunscreen or makeup?

Usually yes once the product has absorbed, but choose non-irritating products. If the skin is weeping or ulcerated, makeup can sting and may increase irritation. Sun protection is important during treatment and for weeks afterwards. (6,7)

Can I cover the area with a dressing?

Not usually. Occlusive (airtight) dressings can intensify the reaction and may increase side effects. If you need cover for cosmetic reasons, a light, non-occlusive dressing may be acceptable — discuss it with your doctor first. (6,7)

Can Aldara (imiquimod) be used near the eye, nose, or lips?

Extra caution is needed near mucous membranes. Accidental transfer to eyes or lips can cause significant irritation. If your lesion is close to these areas, you should only treat it under clear instructions (and sometimes we’ll recommend an in-clinic option instead). (6,7)

Will Aldara (imiquimod) leave a scar?

Most people do not scar, but scarring can happen — especially if inflammation is severe, prolonged, or the site heals poorly (such as lower legs). If scarring risk is a major concern, discuss alternatives like (Laser-assisted photodynamic therapy (LA-PDT) for non-melanoma skin cancer) or surgery where appropriate. (6,7)

Can Aldara (imiquimod) cause pigmentation changes?

Yes. Any significant inflammation can trigger temporary or permanent darkening (hyperpigmentation) or lightening (hypopigmentation), especially in pigment-prone skin types or with sun exposure. If pigmentation is a major concern, see (Post-Inflammatory Hyperpigmentation)and (Melasma). (6,7)

Is Aldara (imiquimod) safe in pregnancy or breastfeeding?

Aldara (imiquimod) is generally avoided in pregnancy, and product information advises caution in breastfeeding due to limited data. Always tell your doctor if you are pregnant, trying to conceive, or breastfeeding. (6,7)

What are alternatives if I don’t want Aldara (imiquimod)?

Depending on the diagnosis, alternatives may include (Efudix (5-fluorouracil)), (Laser-assisted photodynamic therapy (LA-PDT) for non-melanoma skin cancer), or surgery. For AK field treatment options, see (Actinic Keratosis Treatment). (6,7,10)

How do you confirm the cancer is gone after treatment?

We usually reassess clinically and with dermoscopy after the course. If there is any doubt, persistent change, or recurrence, a biopsy may be recommended to confirm clearance. (1–5)

References